Overview
Investors searching ETC vs INJ usually want a clear market-cap and momentum snapshot. ETC prints $6.62 (+2.32%) while Injective is at $5.08 (+4.65%), with volume edge currently on Injective.
Quick winners
Full comparison
| Metric | ETC | INJ |
|---|---|---|
| Price | $6.62 | $5.08 |
| Market Cap | $1.04B | $490.41M |
| FDV | — | — |
| Volume 24h | $1.01M | $2.27M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 64.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | ETC | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +2.32% | +4.65% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | ETC | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 63.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (58.40 vs 47.50) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | ETC | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
ETC
Injective
Pros and cons
Pros of ETC
- ETC often anchors narratives that attract sustained media and analyst coverage.
- Market-cap scale on ETC may dampen some idiosyncratic shocks versus smaller peers.
- Composite PEPS readings for ETC can surface clearer module agreement during trend phases.
Cons of ETC
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Regulatory or macro headlines can hit ETC harder simply because it is more visible.
- Indicator stacks on ETC may stay stretched longer than expected in strong trends.
Pros of Injective
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
Cons of Injective
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
Which looks stronger right now?
If you weight capitalization and liquidity, ETC looks sturdier; if you weight 24h tape, Injective is ahead. A balanced view treats both as incomplete signals.
AI summary
This AI-assisted summary starts from live PEPS fields. ETC holds market-cap $1.04B and rank #64; Injective shows $490.41M and #99. Where liquidity and flow matter, watch Injective. Where durability matters, watch ETC. AI composite scores (58.40/47.50) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, ETC or Injective?
“Better” depends on horizon and risk. ETC leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, ETC or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both ETC and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.